In this issue:
- Diabetes and thromboembolic event risk during SARS-COV-2 infection
- Impact of oral glucose-lowering medications on basal insulin titration in type 2 diabetes
- Comparative mortality in type 1 diabetes in the community
- Burden of diabetes 1990–2021, and projections to 2050
- Triple-hormone-receptor agonist retatrutide for obesity
- Time-restricted eating for weight loss
- Glycaemic control in prediabetes managed with metformin
- Mean age and BMI at type 2 diabetes diagnosis
- Artificial sweeteners increase type 2 diabetes risk
- SGLT-2 inhibitor safety in elderly patients with type 2 diabetes
Please login below to download this issue (PDF)